苏尔法米托克萨-三甲预防儿科瘤学患者与葡萄糖-6-酸盐脱酶缺乏症
Rachael M Stone1, Cyrine E Haidar1, Nancy M Kornegay1
1From the Department of Pharmacy and Pharmaceutical Sciences.
The Pediatric infectious disease journal
|August 20, 2024
概括
硫甲醇-三甲胺 (SMX-TMP) 预防措施不会增加患有葡萄糖-6-酸盐脱酶 (G6PD) 缺乏症的儿科瘤病人的急性血液溶解性贫血风险. 研究表明,在G6PD缺乏和非缺乏组之间,血红蛋白水平或输血需求没有显著差异.
科学领域:
- 儿科血液学 儿科血液学
- 在瘤学瘤学.
- 传染病预防 传染病预防
背景情况:
- 葡萄糖-6-酸盐脱酶 (G6PD) 缺乏症是一种常见的遗传疾病,可能导致溶血性贫血.
- 肺炎 (PJP) 是一种严重的机会性感染在免疫功能低下的患者,特别是那些接受癌症治疗.
- 硫甲-三甲 (SMX-TMP) 是一种针对PJP的标准预防剂,但人们对其在G6PD缺乏个体中引发血解的潜力存在担忧.
研究的目的:
- 为了研究SMX-TMP预防与患有G6PD缺乏症的儿科瘤病人的急性血液溶解性贫血之间的关联.
- 为了比较接受SMX-TMP.的G6PD缺乏与非G6PD缺乏儿科瘤患者的血液溶解和输血需求的发生率.
主要方法:
- 对接受SMX-TMP用于PJP预防的儿科瘤患者的回顾性图表审查.
- 在G6PD缺乏和没有G6PD缺乏的患者之间比较血红蛋白水平的变化和输血需要.
- 统计分析以确定观察到的差异的意义.
主要成果:
- 在开始SMX-TMP后,在G6PD缺乏和非G6PD缺乏组之间没有观察到血红蛋白水平变化的统计学上显著差异.
- 在两组之间,输血要求没有显著差异.
- 该研究没有发现G6PD缺乏患者急性血液溶解性贫血的频率增加的证据.
结论:
- 用于预防剂量的SMX-TMP在患有G6PD缺乏症的儿科瘤患者中似乎是安全的.
- 在接受SMX-TMP用于PJP预防的G6PD缺乏患者中,急性血液溶解性贫血的风险没有显著增加.
- 这些发现支持继续使用SMX-TMP用于这种脆弱人群的PJP预防.
相关概念视频
01:27Glucose Transporters
22.6K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.6K
01:20Inborn Errors of Metabolism
148
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
148
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K